Literature DB >> 18645512

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Charlotte Lewden1, Thierry May, Eric Rosenthal, Christine Burty, Fabrice Bonnet, Dominique Costagliola, Eric Jougla, Caroline Semaille, Philippe Morlat, Dominique Salmon, Patrice Cacoub, Geneviève Chêne.   

Abstract

BACKGROUND: The multicenter national Mortalité 2005 survey aimed at describing the distribution of causes of death among HIV-infected adults in France in 2005 and its changes as compared with 2000.
METHODS: Physicians involved in the management of HIV infection notified deaths and documented the causes using a standardized questionnaire similar to the previous survey performed in 2000.
RESULTS: Overall, 1042 deaths were notified in 2005 (vs 964 in 2000): with median age, 46 years (vs 41 years); men, 76%; and median last CD4 cell count, 161/mm (vs 94). The proportion of underlying causes of death due to AIDS decreased (36% in 2005 vs 47% in 2000), and the proportion of cancer not related to AIDS or hepatitis (17% vs 11%), liver related disease (15% vs 13%: hepatitis C, 11%, and hepatitis B, 2%), cardiovascular disease (8% vs 7%), or suicide (5% vs 4%) increased. Among the 375 AIDS-related deaths, the most frequent event was non-Hodgkin lymphoma (28%). Among cancers not related to AIDS or hepatitis, the most frequent localizations were lung (31%) and digestive tract (14%). Among the 154 liver-related deaths, 24% were due to hepatocarcinoma.
CONCLUSIONS: The heterogeneity of causes of death among HIV-infected adults was confirmed and intensified in 2005, with 3 causes following AIDS: cancers and liver-related and cardiovascular diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18645512     DOI: 10.1097/QAI.0b013e31817efb54

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  110 in total

1.  Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil.

Authors:  Antonio G Pacheco; Valeria Saraceni; Suely H Tuboi; Lilian M Lauria; Lawrence H Moulton; José Cláudio Faulhaber; Bonnie King; Jonathan E Golub; Betina Durovni; Solange Cavalcante; Lee H Harrison; Richard E Chaisson; Mauro Schechter
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  Commentary: can mortality rates among adult antiretroviral therapy patients in Europe reach levels similar to those experienced in the general population?

Authors:  Andrew F Auld; Tedd V Ellerbrock
Journal:  Int J Epidemiol       Date:  2012-03-06       Impact factor: 7.196

3.  Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

Authors:  Jacqueline Neuhaus; Brian Angus; Justyna D Kowalska; Alberto La Rosa; Jim Sampson; Deborah Wentworth; Amanda Mocroft
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

4.  Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.

Authors:  Rosemary Dray-Spira; Camille Legeai; Mariette Le Den; François Boué; Caroline Lascoux-Combe; Anne Simon; Thierry May; Cécile Goujard; Laurence Meyer
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

5.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

6.  Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.

Authors:  Helen Kovari; Caroline A Sabin; Bruno Ledergerber; Lene Ryom; Signe W Worm; Colette Smith; Andrew Phillips; Peter Reiss; Eric Fontas; Kathy Petoumenos; Stéphane De Wit; Philippe Morlat; Jens D Lundgren; Rainer Weber
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

7.  Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy.

Authors:  Wanwarang Wongcharoen; Kolakrit Khienprasit; Arintaya Phrommintikul; Apichard Sukonthasarn; Nipon Chattipakorn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-06-09       Impact factor: 1.468

8.  HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways.

Authors:  Rachel P Simmons; Eileen P Scully; Erin E Groden; Kelly B Arnold; J Judy Chang; Kim Lane; Jeff Lifson; Eric Rosenberg; Douglas A Lauffenburger; Marcus Altfeld
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

9.  Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.

Authors:  Stephen R Cole; Sonia Napravnik; Michael J Mugavero; Bryan Lau; Joseph J Eron; Michael S Saag
Journal:  Am J Epidemiol       Date:  2009-12-09       Impact factor: 4.897

Review 10.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.